Paola Moreno - Concepedia

Author

Paola Moreno

National Institute of Diabetes and Digestive and Kidney Diseases

Also Known As

Paola Moreno

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

National Institute of Diabetes and Digestive and Kidney Diseases National Institutes of Health Hospital Universitario Fundación Jiménez Díaz Center for Cancer Research Office of the Director

About

Paola Moreno is an author at National Institute of Diabetes and Digestive and Kidney Diseases specializing in medicine, physiology, and diabetes.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	14	611
2	Health Sciences	5	5	388
3	Biochemistry	2	2	54
4	Natural Sciences	1	1	12
5	Biomolecular Engineering	1	1	141

Paola Moreno

Publications

901

Citations

H-Index

Page 1

	Year	Citations
Effect of GLP-1 Treatment on Bone Turnover in Normal, Type 2 Diabetic, and Insulin-Resistant States Bernardo Nuche‐Berenguer, Paola Moreno, Pedro Esbrit, Calcified Tissue International Bone HealthGlp-1 TreatmentInsulin ManagementPhysiologyDiabetes	2009	188
Exendin-4 exerts osteogenic actions in insulin-resistant and type 2 diabetic states Bernardo Nuche‐Berenguer, Paola Moreno, Sergio Portal‐Núñez, Regulatory Peptides Metabolic SyndromeInsulin SignalingSclerostinBone Morphogenic ProteinDiabetic States	2009	141
Presence of a functional receptor for GLP‐1 in osteoblastic cells, independent of the cAMP‐linked GLP‐1 receptor Bernardo Nuche‐Berenguer, Sergio Portal‐Núñez, Paola Moreno, Journal of Cellular Physiology	2010	141
GLP-1 and exendin-4 can reverse hyperlipidic-related osteopenia Bernardo Nuche‐Berenguer, Daniel Lozano, Irene Gutiérrez-Rojas, Journal of Endocrinology	2011	90
A structure–function study of PACAP using conformationally restricted analogs: Identification of PAC1 receptor-selective PACAP agonists Irene Ramos-Álvarez, Samuel A. Mantey, Taichi Nakamura, Peptides Molecular PharmacologyMolecular PhysiologySignal TransductionBiochemistryStructure–function Study	2015	44
Comparative Pharmacology of Bombesin Receptor Subtype-3, Nonpeptide Agonist MK-5046, a Universal Peptide Agonist, and Peptide Antagonist Bantag-1 for Human Bombesin Receptors Paola Moreno, Samuel A. Mantey, Bernardo Nuche‐Berenguer, Journal of Pharmacology and Experimental Therapeutics	2013	35
A possible new target in lung-cancer cells: The orphan receptor, bombesin receptor subtype-3 Paola Moreno, Samuel A. Mantey, Suk‐Hee Lee, Peptides MedicineBombesin Receptor Subtype-3Receptor (Biochemistry)Bronchial NeoplasmOrphan Receptor	2018	35
Gastrointestinal hormones stimulate growth of Foregut Neuroendocrine Tumors by transactivating the EGF receptor Alessia Di Florio, Verónica Sancho, Paola Moreno, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research Tumor InnervationGastrointestinal HormonesForegut Neuroendocrine TumorsNeuroendocrine DisorderGastroenterology	2012	34
SR48692 inhibits non-small cell lung cancer proliferation in an EGF receptor-dependent manner Terry W. Moody, Daniel C. Chan, Samuel A. Mantey, Life Sciences Tumor BiologyOncologyLung InflammationMedicineCancer Cell Biology	2014	30
ML-18 is a non-peptide bombesin receptor subtype-3 antagonist which inhibits lung cancer growth Terry W. Moody, Samuel A. Mantey, Paola Moreno, Peptides OncologyMedicineImmunologyLung Cancer GrowthBronchial Neoplasm	2014	27

Page 1